Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent
First Claim
1. A method of increasing the battery life of an alternating current iontophoretic device used to transport a compound of interest through a localized region of a patient'"'"'s body tissue, comprising:
- (a) applying an alternating current to a localized region of body tissue having an inherent barrier limiting the transport of compounds therethrough, the alternating current generated using an alternating current iontophoretic device and applied at a level sufficient both to decrease the electrical resistance of the body tissue to a target resistance level and to maintain the electrical resistance of the body tissue at said target level; and
(b) either prior to, during, or both prior to and during application of the alternating current, delivering to the localized region of body tissue an amount of at least one barrier-modifying agent effective to alter the penetration barrier so as to reduce the voltage level necessary to achieve and maintain said target resistance level thereby facilitating transport of a compound of interest across the body tissue.
1 Assignment
0 Petitions
Accused Products
Abstract
An iontophoretic method for transporting compounds of interest across a body tissue is provided. The method utilizes an AC signal in conjunction with a barrier-modifying agent such as a fatty acid, fatty alcohol, bile acid, surfactant, or the like. The method enables the maintenance of a substantially constant electrical state in a localized region of the tissue through which transport occurs, thereby allowing a compound of interest to be transported across the tissue in a controlled and predictable manner. The barrier-modifying agent reduces the time as well as the voltage level required to achieve a target electrical resistance, thereby reducing patient discomfort and increasing the battery life of the iontophoresis device.
-
Citations
61 Claims
-
1. A method of increasing the battery life of an alternating current iontophoretic device used to transport a compound of interest through a localized region of a patient'"'"'s body tissue, comprising:
-
(a) applying an alternating current to a localized region of body tissue having an inherent barrier limiting the transport of compounds therethrough, the alternating current generated using an alternating current iontophoretic device and applied at a level sufficient both to decrease the electrical resistance of the body tissue to a target resistance level and to maintain the electrical resistance of the body tissue at said target level; and
(b) either prior to, during, or both prior to and during application of the alternating current, delivering to the localized region of body tissue an amount of at least one barrier-modifying agent effective to alter the penetration barrier so as to reduce the voltage level necessary to achieve and maintain said target resistance level thereby facilitating transport of a compound of interest across the body tissue. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51)
-
-
52. An alternating current iontophoresis device for extracting an analyte from a patient'"'"'s body beneath a localized region of body tissue, comprising:
-
a) a first electrode assembly adapted to receive an analyte and be placed in ion-conducting and analyte-receiving relation with respect to the localized region of body tissue, the assembly comprising a reservoir for collecting and containing an analyte extracted from the patient'"'"'s body beneath the localized region;
b) a second electrode assembly adapted to be placed in ion-transmitting relation with the body tissue at a location spaced apart from the first electrode assembly; and
c) an alternating current source electrically connected to the first and second electrode assemblies, for applying an alternating current to the localized region of body tissue at a level sufficient to achieve and maintain a target electrical resistance within the tissue, wherein at least one of the first and second electrode assemblies further comprises a barrier-modifying agent for delivery to the localized region of the body tissue, said agent effective to reduce the voltage required to achieve and maintain said target electrical resistance. - View Dependent Claims (53, 54, 55, 56, 58, 59, 60, 61)
-
-
57. An alternating current iontophoresis device for delivering a pharmacologically active agent to a patient through a localized region of the patient'"'"'s body surface, comprising:
-
a) a first electrode assembly adapted to be placed in ion-conducting and compound-delivering relation with the localized region of the body surface and comprising a reservoir housing a pharmacologically active agent to be transported into and through the body surface; and
b) a second electrode assembly adapted to be placed in ion-transmitting relation with the body surface at a location spaced apart from the first electrode assembly; and
c) an alternating current source electrically connected to the first and second electrode assemblies, for applying an alternating current to the localized region of body tissue at a level sufficient to achieve and maintain a target electrical resistance within the localized region, wherein at least one of the first and second electrode assemblies further comprises a barrier-modifying agent for delivery to the localized region of the body tissue, said agent effective to reduce the voltage necessary to achieve and maintain a target electrical resistance within the localized region.
-
Specification